Press Coverage

Cellvizio Technology Helps Detect Precancerous Cells

10 October 2018

Read the full article on "Dr. Stephen Matter M.D. in Normal, Illinois using a fairly new technology to detect and diagnose precancerous conditions in the esophagus. He treats patients with chronic heartburn, acid reflux and indigestion caused by stomach acid getting into the esophagus."

Latest News

Mauna Kea Technologies Announces the Results of its Combined General Meeting of June 4, 2026

Mauna Kea Technologies Announces the Results of its Combined General Meeting of June 4, 2026

Mauna Kea Technologies Announces New Publication in the UEG Journal Identifying “Triple Healing”, a Cellvizio®— Assessed Therapeutic Target Associated with Sustained Remission in Ulcerative Colitis

Mauna Kea Technologies Announces New Publication in the UEG Journal Identifying “Triple Healing”, a Cellvizio®— Assessed Therapeutic Target Associated with Sustained Remission in Ulcerative Colitis

Mauna Kea Technologies Expands Presence in the Middle East with UAE and Turkey Regulatory Approvals and First CellTolerance® Commercial Installation

Mauna Kea Technologies Expands Presence in the Middle East with UAE and Turkey Regulatory Approvals and First CellTolerance® Commercial Installation

No results found.